Chemo-Induced Nausea/Vomiting (CINV)

BC Cancer Protocol

• Antiemetic regmiens and dosing

BC Cancer Symptom Management

• Guidelines for managing chemo-induced nausea/vomiting 

1. What is the % risk of emesis for a chemotherapy protocol that has moderate emetogenic potential? 

a) >90%

b) 30-90%

c) 10-30%

d) <10%

2. Patient experiences nausea and vomiting 12 hours following chemotherapy. What type of CINV is this? 

a) Anticipatory 

b) Acute

c) Delayed

d) Refractory

3. What is the most important goal of therapy for CINV?

a) Treat signs/symptoms of CINV

b) Maintain oral intake and appetite 

c) Prevent CINV

d) Prevent delay in chemotherapy treatment

4. The following are risk factors for CINV EXCEPT? 

a) Female

b) Brain metastasis

c) Younger age (<50 years old)

d) Alcohol consumption

5. What medications should be given before chemotherapy in a patient recieving the BRAJDC protocol?

a) NK1Ra + 5-HT3a + Dex +/- Olanzapine 

b) 5-HT3a + Dex +/- Olanzapine 

c) Dexamethasone

d) None